Gard Paul R, Rusted Jennifer M
School of Pharmacy & Biomolecular Sciences, University of Brighton, Brighton, BN2 4GJ, UK.
Expert Rev Neurother. 2004 Jan;4(1):87-96. doi: 10.1586/14737175.4.1.87.
This review describes the features of Alzheimer's disease and discusses the evidence that antihypertensive therapies may be beneficial in its treatment and prevention. Drugs acting via the renin-angiotensin system are considered and it is suggested that these drugs may produce their effects via mechanisms other than by their antihypertensive actions. Using evidence from animal studies, the role of angiotensin as a neurotransmitter and its involvement in the control of normal cognitive function is described. Studies of angiotensin and human cognition are reviewed along with studies investigating the possible link between disorders of the system, either inherited or acquired, and the symptoms of Alzheimer's disease. The therapeutic potential of screening for markers of renin-angiotensin abnormality for the prediction of Alzheimer's disease is considered, as is the potential use of agents known to influence the renin-angiotensin system in the treatment or prevention of the disease.
本综述描述了阿尔茨海默病的特征,并讨论了抗高血压疗法可能对其治疗和预防有益的证据。文中考虑了通过肾素-血管紧张素系统起作用的药物,并指出这些药物可能通过其降压作用以外的机制产生效果。利用动物研究的证据,描述了血管紧张素作为神经递质的作用及其在正常认知功能控制中的参与情况。回顾了血管紧张素与人类认知的研究,以及调查该系统遗传性或获得性紊乱与阿尔茨海默病症状之间可能联系的研究。文中考虑了筛查肾素-血管紧张素异常标志物以预测阿尔茨海默病的治疗潜力,以及已知影响肾素-血管紧张素系统的药物在该病治疗或预防中的潜在用途。